Consort Medical plc Market Share Analysis

  • February 2013
  • -
  • Global Data
  • -
  • 116 pages

Consort Medical plc Market Share Analysis



Summary



GlobalData’s new report, “Consort Medical plc Market Share Analysis” provides in-depth information on Consort Medical plc’s market position in the different medical equipment markets it operates in. The report provides Consort Medical plc market share information in two key market categories – Metered Dose Inhaler Devices and Needle Free Injections. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Global company shares (in Revenues) information for the key markets Consort Medical plc operates in –Drug Delivery Devices.
- Consort Medical plc’s company shares (in Revenues) information for all the key countries the company has presence in – Australia, Spain, France, Germany, Italy, United Kingdom, India, United States, Japan, Canada, China and Brazil.
- Consort Medical plc’s company shares (in Revenues) information for all the key market categories the company has presence in – Metered Dose Inhaler Devices and Needle Free Injections.
- All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.



Reasons to buy


- Develop sales and marketing strategies by identifying who-stands-where in the markets, Consort Medical plc operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Consort Medical plc’s market positions.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Drug Delivery Devices 11
3.1.1 Metered Dose Inhaler Devices 11
3.1.2 Needle Free Injections 11
4 Company Snapshot 12
4.1 Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
5 Business Description 13
5.1 Business Overview 13
5.2 Bespak - Drug Delivery Device 14
5.2.1 Overview 14
5.2.2 Financials 14
5.2.3 Capital Expenditure 14
5.2.4 Market View 14
5.3 King Systems - Anaesthesia Products 14
5.3.1 Overview 14
5.3.2 Financials 14
5.3.3 Capital Expenditure 14
5.3.4 Market View 14
5.4 Major Products and Services 15
5.4.1 Overview 15
6 History 16
7 SWOT Analysis 19
7.1 Overview 19
7.2 Consort Medical plc Strengths 20
7.2.1 Successful Integration of The Medical House 20
7.2.2 Focused Research and Development Activities 20
7.2.3 Geographical Diversity 20
7.2.4 Strong Liquidity Position 20
7.3 Consort Medical plc Weaknesses 21
7.3.1 Product Recalls 21
7.3.2 High Debt 21
7.4 Consort Medical plc Opportunities 22
7.4.1 Expansion in New Markets 22
7.4.2 Global Anesthesia and Respiratory Devices Market 22
7.4.3 Growing Aged Population 22
7.4.4 Emerging Inhaled Drug Delivery Market 23
7.5 Consort Medical plc Threats 24
7.5.1 Rapid Technological Changes 24
7.5.2 Stringent Government Regulations 24
7.5.3 Intense Competition 24
7.5.4 Industry Consolidation Challenges 24
8 Competitors 25
9 Competitive Landscape 26
9.1 Drug Delivery Devices (Metered Dose Inhaler Devices), Global, Market Share (%), 2011 26
9.2 Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Region, Market Share (2011) 28
9.3 Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Country, Market Share (2011) 29
9.4 Drug Delivery Devices (Needle Free Injections), Global, Market Share (%), 2011 31
9.5 Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Region, Market Share (2011) 32
9.6 Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Country, Market Share (2011) 33
9.7 Consort Medical plc, Drug Delivery Devices, Global, Category Revenue Share (2011) 35
9.8 Consort Medical plc, Asia-Pacific, Category Revenue Share (2011) 37
9.8.1 Consort Medical plc, Australia, Category Revenue Share (2011) 39
9.8.2 Consort Medical plc, China, Category Revenue Share (2011) 41
9.8.3 Consort Medical plc, Japan, Category Revenue Share (2011) 43
9.8.4 Consort Medical plc, Other Asia-Pacific, Category Revenue Share (2011) 45
9.9 Consort Medical plc, Europe, Category Revenue Share (2011) 46
9.9.1 Consort Medical plc, France, Category Revenue Share (2011) 48
9.9.2 Consort Medical plc, Germany, Category Revenue Share (2011) 50
9.9.3 Consort Medical plc, Italy, Category Revenue Share (2011) 52
9.9.4 Consort Medical plc, Spain, Category Revenue Share (2011) 54
9.9.5 Consort Medical plc, United Kingdom, Category Revenue Share (2011) 56
9.9.6 Consort Medical plc, Other Europe, Category Revenue Share (2011) 58
9.10 Consort Medical plc, Middle East and Africa, Category Revenue Share (2011) 60
9.11 Consort Medical plc, North America, Category Revenue Share (2011) 62
9.11.1 Consort Medical plc, Canada, Category Revenue Share (2011) 64
9.11.2 Consort Medical plc, United States, Category Revenue Share (2011) 66
9.12 Consort Medical plc, South and Central America, Category Revenue Share (2011) 68
9.12.1 Consort Medical plc, Brazil, Category Revenue Share (2011) 70
9.12.2 Consort Medical plc, Other South and Central America, Category Revenue Share (2011) 72
10 Key Employees 74
11 Key Employee Biographies 75
12 Company Statement 76
13 Locations And Subsidiaries 77
13.1 Head Office 77
13.2 Other Locations and Subsidiaries 77
14 Financial Deals Landscape 79
14.1 Consort Medical plc, Deals Volume Summary, 2007 to 2012 79
15 Consort Medical plc, Deals Summary By Region, 2007 to 2012 80
16 Consort Medical plc Detailed Deal Summary 82
16.1 Venture Financing 82
16.1.1 Atlas Genetics Raises $27 Million In Series B Financing 82
16.2 Partnerships 84
16.2.1 Consort Medical Enters Into Co-Development Agreement With Atlas Genetics 84
16.2.2 King Systems Enters Into Distribution Agreement With Beijing Gloryway Technology 85
16.2.3 Bespak Enters Into Co-Development Agreement With Zogenix 86
16.3 Acquisition 87
16.3.1 Ambu To Acquire King Systems From Consort Medical For Up To $170 Million 87
16.3.2 Consort Medical Completes The Acquisition Of Medical House 89
16.3.3 King Systems Acquires Majority Interest In Emergent Respiratory Products 91
17 Recent Developments 92
17.1 Strategy And Business Planning 92
17.1.1 Aug 03, 2006: Bespak To Withdraw From Consumer Dispensers Business 92
17.2 Financial Announcements 92
17.2.1 Dec 05, 2012: Consort Medical Reports Revenue Of £69.9m In H1 Fiscal 2013 92
17.2.2 Jul 28, 2011: Consort Medical Reports Total Revenues Of £132.4m In Fiscal 2011 93
17.2.3 Dec 02, 2010: Consort Medical Reports Total Revenues Of GBP69.6 Million In H1 Fiscal 2011 94
17.2.4 Jun 17, 2010: Consort Medical Reports Preliminary Fiscal 2010 Results 94
17.2.5 Dec 10, 2009: Consort Medical Reports Total Revenues Of GBP61.5 Million In H1 Fiscal 2010 95
17.2.6 Jun 24, 2009: Consort Medical Reports Preliminary Results For Fiscal 2009 97
17.2.7 Dec 11, 2008: Consort Medical Declares Interim Dividend 98
17.2.8 Dec 11, 2008: Consort Medical 1H Fiscal 2009 Results 98
17.2.9 Jan 18, 2007: Bespak Declares Interim Results 100
17.2.10 Nov 07, 2006: Bespak Sees To Beat Own Expectations 102
17.2.11 Jul 12, 2006: Bespak Declares 2006 Results 103
17.3 Corporate Communications 106
17.3.1 Dec 02, 2010: Consort Appoints Nick Higgins As Executive Director 106
17.3.2 May 21, 2010: Consort Medical Appoints Keyvan Djamarani As Group Director, Operations 106
17.3.3 Oct 13, 2009: Consort Medical Announces Departure Of Paul Boughton As Corporate Development Director 106
17.3.4 May 06, 2009: Consort Medical Appoints Dr William Jenkins As An Independent Non-Executive Director 107
17.3.5 Feb 13, 2009: Consort Medical Appoints New Chairman 107
17.3.6 Jun 24, 2008: Consort Medical Appoints Group Finance Director 108
17.3.7 Dec 05, 2007: Consort Medical Appoints CEO 108
17.3.8 Feb 16, 2007: Bespak Appoints Head Of Corporate Communications 108
17.3.9 Sep 28, 2006: Bespak To Hold Its AGM 109
17.3.10 Aug 31, 2006: Bespak Appoints Non-Executive Director 109
17.3.11 Jul 27, 2006: Bespak Appoints Group Finance Director 110
17.4 Product News 110
17.4.1 Oct 03, 2011: Bespak Wins Contract To Develop Unidose Nasal Drug Delivery Device 110
17.5 Other Significant Developments 111
17.5.1 May 03, 2007: Bespak Expects Strong Financials 111
17.5.2 Apr 03, 2007: Bespak To Raise Funds For The British Lung Foundation 111
18 Appendix 112
18.1 Research Methodology 113
18.2 Secondary Research 113
18.3 Primary Research 113
18.4 Models 114
18.5 Forecasts 114
18.6 Expert Panels 114
18.7 GlobalData Consulting 114
18.8 Currency Conversion 115
18.9 Contact Us 116
18.10 Disclaimer 116

List of Tables

Table 1: Consort Medical plc, Key Facts, 2011 12
Table 2: Consort Medical plc, SWOT Analysis, 2011 19
Table 3: Drug Delivery Devices (Metered Dose Inhaler Devices), Global, Company Share by Revenue ($m), 2011 27
Table 4: Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Region, Revenue ($m) and Market Share (%), 2011 28
Table 5: Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Country, Revenue ($m) and Market Share (%), 2011 30
Table 6: Drug Delivery Devices (Needle Free Injections), Global, Company Share by Revenue ($m), 2011 31
Table 7: Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Region, Revenue ($m) and Market Share (%), 2011 32
Table 8: Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Country, Revenue ($m) and Market Share (%), 2011 34
Table 9: Consort Medical plc, Drug Delivery Devices, Global, Revenue ($m) and Market Share (%) by Category, 2011 36
Table 10: Consort Medical plc, Drug Delivery Devices, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2011 38
Table 11: Consort Medical plc, Drug Delivery Devices, Australia, Revenue ($m) and Market Share (%) by Category, 2011 40
Table 12: Consort Medical plc, Drug Delivery Devices, China, Revenue ($m) and Market Share (%) by Category, 2011 42
Table 13: Consort Medical plc, Drug Delivery Devices, Japan, Revenue ($m) and Market Share (%) by Category, 2011 44
Table 14: Consort Medical plc, Drug Delivery Devices, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2011 45
Table 15: Consort Medical plc, Drug Delivery Devices, Europe, Revenue ($m) and Market Share (%) by Category, 2011 47
Table 16: Consort Medical plc, Drug Delivery Devices, France, Revenue ($m) and Market Share (%) by Category, 2011 49
Table 17: Consort Medical plc, Drug Delivery Devices, Germany, Revenue ($m) and Market Share (%) by Category, 2011 51
Table 18: Consort Medical plc, Drug Delivery Devices, Italy, Revenue ($m) and Market Share (%) by Category, 2011 53
Table 19: Consort Medical plc, Drug Delivery Devices, Spain, Revenue ($m) and Market Share (%) by Category, 2011 55
Table 20: Consort Medical plc, Drug Delivery Devices, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2011 57
Table 21: Consort Medical plc, Drug Delivery Devices, Other Europe, Revenue ($m) and Market Share (%) by Category, 2011 59
Table 22: Consort Medical plc, Drug Delivery Devices, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2011 61
Table 23: Consort Medical plc, Drug Delivery Devices, North America, Revenue ($m) and Market Share (%) by Category, 2011 63
Table 24: Consort Medical plc, Drug Delivery Devices, Canada, Revenue ($m) and Market Share (%) by Category, 2011 65
Table 25: Consort Medical plc, Drug Delivery Devices, United States, Revenue ($m) and Market Share (%) by Category, 2011 67
Table 26: Consort Medical plc, Drug Delivery Devices, South and Central America, Revenue ($m) and Market Share (%) by Category, 2011 69
Table 27: Consort Medical plc, Drug Delivery Devices, Brazil, Revenue ($m) and Market Share (%) by Category, 2011 71
Table 28: Consort Medical plc, Drug Delivery Devices, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2011 73
Table 29: Consort Medical plc, Key Employees 74
Table 30: Consort Medical plc, Other Locations 77
Table 31: Consort Medical plc, Subsidiaries 77
Table 32: Consort Medical plc, Deals Volume Summary, 2007 to 2012 79
Table 33: Consort Medical plc, Deals Summary By Region, 2007 to 2012 80
Table 34: Consort Medical plc, Deals Summary, 2007 to 2012 81
Table 35: Atlas Genetics Raises $27 Million In Series B Financing 82
Table 36: Consort Medical Enters Into Co-Development Agreement With Atlas Genetics 84
Table 37: King Systems Enters Into Distribution Agreement With Beijing Gloryway Technology 85
Table 38: Bespak Enters Into Co-Development Agreement With Zogenix 86
Table 39: Ambu To Acquire King Systems From Consort Medical For Up To $170 Million 87
Table 40: Consort Medical Completes The Acquisition Of Medical House 89
Table 41: King Systems Acquires Majority Interest In Emergent Respiratory Products 91
Table 42: USD to Local Currency, Average Exchange Rate, 2011 115

List of Figures

Figure 1: Drug Delivery Devices (Metered Dose Inhaler Devices), Global, Market Share (%), 2011 26
Figure 2: Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Region, Market Share (%), 2011 28
Figure 3: Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Country, Market Share (%), 2011 29
Figure 4: Drug Delivery Devices (Needle Free Injections), Global, Market Share (%), 2011 31
Figure 5: Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Region, Market Share (%), 2011 32
Figure 6: Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Country, Market Share (%), 2011 33
Figure 7: Consort Medical plc, Drug Delivery Devices, Global, Category Revenue Share (%), 2011 35
Figure 8: Consort Medical plc, Drug Delivery Devices, Global, Market Share (%) by Category, 2011 36
Figure 9: Consort Medical plc, Drug Delivery Devices, Asia-Pacific, Category Revenue Share (%), 2011 37
Figure 10: Consort Medical plc, Drug Delivery Devices, Asia-Pacific, Market Share (%) by Category, 2011 38
Figure 11: Consort Medical plc, Drug Delivery Devices, Australia, Category Revenue Share (%), 2011 39
Figure 12: Consort Medical plc, Drug Delivery Devices, Australia, Market Share (%) by Category, 2011 40
Figure 13: Consort Medical plc, Drug Delivery Devices, China, Category Revenue Share (%), 2011 41
Figure 14: Consort Medical plc, Drug Delivery Devices, China, Market Share (%) by Category, 2011 42
Figure 15: Consort Medical plc, Drug Delivery Devices, Japan, Category Revenue Share (%), 2011 43
Figure 16: Consort Medical plc, Drug Delivery Devices, Japan, Market Share (%) by Category, 2011 44
Figure 17: Consort Medical plc, Drug Delivery Devices, Europe, Category Revenue Share (%), 2011 46
Figure 18: Consort Medical plc, Drug Delivery Devices, Europe, Market Share (%) by Category, 2011 47
Figure 19: Consort Medical plc, Drug Delivery Devices, France, Category Revenue Share (%), 2011 48
Figure 20: Consort Medical plc, Drug Delivery Devices, France, Market Share (%) by Category, 2011 49
Figure 21: Consort Medical plc, Drug Delivery Devices, Germany, Category Revenue Share (%), 2011 50
Figure 22: Consort Medical plc, Drug Delivery Devices, Germany, Market Share (%) by Category, 2011 51
Figure 23: Consort Medical plc, Drug Delivery Devices, Italy, Category Revenue Share (%), 2011 52
Figure 24: Consort Medical plc, Drug Delivery Devices, Italy, Market Share (%) by Category, 2011 53
Figure 25: Consort Medical plc, Drug Delivery Devices, Spain, Category Revenue Share (%), 2011 54
Figure 26: Consort Medical plc, Drug Delivery Devices, Spain, Market Share (%) by Category, 2011 55
Figure 27: Consort Medical plc, Drug Delivery Devices, United Kingdom, Category Revenue Share (%), 2011 56
Figure 28: Consort Medical plc, Drug Delivery Devices, United Kingdom, Market Share (%) by Category, 2011 57
Figure 29: Consort Medical plc, Drug Delivery Devices, Other Europe, Category Revenue Share (%), 2011 58
Figure 30: Consort Medical plc, Drug Delivery Devices, Other Europe, Market Share (%) by Category, 2011 59
Figure 31: Consort Medical plc, Drug Delivery Devices, Middle East and Africa, Category Revenue Share (%), 2011 60
Figure 32: Consort Medical plc, Drug Delivery Devices, Middle East and Africa, Market Share (%) by Category, 2011 61
Figure 33: Consort Medical plc, Drug Delivery Devices, North America, Category Revenue Share (%), 2011 62
Figure 34: Consort Medical plc, Drug Delivery Devices, North America, Market Share (%) by Category, 2011 63
Figure 35: Consort Medical plc, Drug Delivery Devices, Canada, Category Revenue Share (%), 2011 64
Figure 36: Consort Medical plc, Drug Delivery Devices, Canada, Market Share (%) by Category, 2011 65
Figure 37: Consort Medical plc, Drug Delivery Devices, United States, Category Revenue Share (%), 2011 66
Figure 38: Consort Medical plc, Drug Delivery Devices, United States, Market Share (%) by Category, 2011 67
Figure 39: Consort Medical plc, Drug Delivery Devices, South and Central America, Category Revenue Share (%), 2011 68
Figure 40: Consort Medical plc, Drug Delivery Devices, South and Central America, Market Share (%) by Category, 2011 69
Figure 41: Consort Medical plc, Drug Delivery Devices, Brazil, Category Revenue Share (%), 2011 70
Figure 42: Consort Medical plc, Drug Delivery Devices, Brazil, Market Share (%) by Category, 2011 71
Figure 43: Consort Medical plc, Drug Delivery Devices, Other South and Central America, Category Revenue Share (%), 2011 72
Figure 44: Consort Medical plc, Drug Delivery Devices, Other South and Central America, Market Share (%) by Category, 2011 73
Figure 45: Consort Medical plc, Deals Volume Summary, 2007 to 2012 79
Figure 46: Consort Medical plc, Deals Summary By Region, 2007 to 2012 80

Companies Mentioned
GlaxoSmithKline plc
AstraZeneca PLC
Boehringer Ingelheim GmbH
3M Health Care Ltd.
Sunovion Pharmaceuticals Inc.
Cipla Medpro (Pty) Ltd.
Cipla Ltd.
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
Antares Pharma, Inc.
PharmaJet, Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Futura Medical plc - Product Pipeline Review - 2014

Futura Medical plc - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Futura Medical plc - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Futura Medical plc - Product Pipeline Review - 2014', provides an overview of the Futura Medical plc's pharmaceutical ...

ReNeuron Group plc - Product Pipeline Review - 2014

ReNeuron Group plc - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

ReNeuron Group plc - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘ReNeuron Group plc - Product Pipeline Review - 2014', provides an overview of the ReNeuron Group plc's pharmaceutical ...

Immupharma Plc - Product Pipeline Review - 2014

Immupharma Plc - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Immupharma Plc - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Immupharma Plc - Product Pipeline Review - 2014', provides an overview of the Immupharma Plc's pharmaceutical research ...


1 Companies

Company Profiles

Hitachi Ltd.

Japan

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.